Abstract
To determine the prevalence of gastrointestinal parasites and evaluate the effect of a single dose of treatment with albendazole in a sentinel group from a rural community in southern Mexico. Stool samples were collected from 1456 individuals aged ≥1 year during consecutive days, and examined for helminth infection using the modified Stoll dilution method. Additionally, 104 individuals were treated with a single dose of albendazole and evaluated over 21 weeks to assess reinfection. Questionnaires were administered to obtain individual and household-level data pertaining to behavior, demography, and socioeconomic status. Risk factors for reinfection after albendazole administration were determined using multiple logistic regression analyses. The prevalence of Ascaris lumbricoides was 73.9% (95% confidence interval [CI] = 71.56%-76.14%). Albendazole was 100% effective, but eggs began to be detected by 9-12 weeks posttreatment, increasing to 100% after 21 weeks. Logistic regression analysis revealed that all individuals from this study had a probability of reinfection of 1.65× each week after treatment. The prevalence of Trichuris trichiura was 57.2% (95% CI = 54.62%-59.77%) and chemotherapy was 34.7% effective. The prevalence for other minor gastrointestinal parasites ranged from 0.2% to 29.7%. This was a comprehensive study on gastrointestinal parasites in a rural community from southern Mexico and, to the best of the authors' knowledge, is the first time that the effect of albendazole has been evaluated for a period of over 21 weeks following its administration. Risk factors associated with parasite transmission were linked to poverty and lack of hygiene, such as, defecating in open places, living customs (drinking piped water and/or from a well), and absence of knowledge about transmission life cycle of the parasites. Studies of this kind should be linked to health education and improvement of access to clean water and adequate sanitation to consolidate morbidity control and enhance sustainability.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
